Skip to the page

Data / Form D filings / Galibra Neuroscience, Inc.

Galibra Neuroscience, Inc.: Form D filing

Galibra Neuroscience, Inc., a health care company in Chestnut Hill, MA, filed a Form D with the SEC in 2024. The latest, on January 24, 2024, reports $100,000 sold of a $1 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
75 WOLCOTT ROAD, Chestnut Hill, MA, 02467
Phone
(617) 510-5949
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2008971

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 24, 2024New notice$1,000,000$100,000$900,0001Jan 10, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Alexander RotenbergExecutive Officer, Director
Hing Cheong LeeExecutive Officer, Director

Other health care companies in Massachusetts that filed recently

Every Form D from the week of Jan 22, 2024 · All recent filings in Massachusetts · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Galibra Neuroscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.